The first court hearing in litigation against the Inflation Reduction Act’s Medicare drug price negotiation program will be a barometer for how the various claims by industry may fare and determine if implementation of the program may be temporarily halted.
Court Could Pause Medicare Drug Price Negotiation Process Following First Hearing In IRA Litigation
Ahead of Friday’s hearing on US Chamber of Commerce's suit against HHS, attorneys discuss potential remedies and carveouts to Inflation Reduction Act's drug price negotiation provisions, harms to industry that may support a preliminary injunction, and what would prompt Supreme Court review.
